Press/Media
- 375 - 400 out of 2,686 results
Search results
-
Study Results from Icahn School of Medicine in the Area of Pancreatic Cancer Reported (Adherence To Nccn Genetic Testing Guidelines In Pancreatic Cancer and Impact On Treatment)
Fionnuala Crowley, Deirdre Cohen & Mantej Sehmbhi
14/04/23
1 item of Media coverage
Press/Media
-
New Multiple Myeloma Study Findings Recently Were Reported by Researchers at Icahn School of Medicine at Mount Sinai (Interventions and Outcomes of Patients With Multiple Myeloma Receiving Salvage Therapy After Bcma-directed Car T Therapy)
David Melnekoff, Joshua Richter, Samir Parekh, Sundar Jagannath, Ajai Chari, Tarek Mouhieddine, Cesar Rodriguez & Yogita Ghodke
13/04/23
1 item of Media coverage
Press/Media
-
-
-
Researchers at Department of Obstetrics Release New Study Findings on Gynecologic Cancer (The use of Instagram by gynecologic oncology providers as a patient education tool for patients at high-risk of gynecologic cancer)
Caitlin Carr, Stephanie Blank & Kristen Zeligs
11/04/23
1 item of Media coverage
Press/Media
-
Evaluating Treatment Options by Patient Type in Multiple Myeloma
8/04/23
1 item of Media coverage
Press/Media
-
Discovery of a drug combination for the treatment of malignant head and neck cancer
7/04/23
1 item of Media coverage
Press/Media
-
Drug Combo Shows Promise Against Advanced Head and Neck Cancer
5/04/23
1 item of Media coverage
Press/Media
-
Imetelstat Displays Early Efficacy in Myelofibrosis; Phase 3 Trial Is Underway
4/04/23
1 item of Media coverage
Press/Media
-
Man, 38, thought he had a hemorrhoid. It was colon cancer
Karyn Goodman & Vishruta Dumane
4/04/23
2 items of Media coverage
Press/Media
-
Drug Combo Shows Promise Against Advanced Head and Neck Cancer
3/04/23
98 items of Media coverage
Press/Media
-
Recap: Teclistamab in Multiple Myeloma: A Patient's Journey
3/04/23
1 item of Media coverage
Press/Media
-
Drug Combo Shows Promise Against Advanced Head and Neck Cancer
3/04/23
1 item of Media coverage
Press/Media
-
Rusfertide Improves Responses, Meets Primary End Point of REVIVE Trial in Polycythemia Vera
3/04/23
2 items of Media coverage
Press/Media
-
Drug Combo Shows Promise Against Advanced Head and Neck Cancer.(ficlatuzumab and cetuximab)
3/04/23
1 item of Media coverage
Press/Media
-
Immunotherapy after surgery is beneficial for high-risk bladder cancer patients
3/04/23
1 item of Media coverage
Press/Media
-
Recap: Teclistamab in Multiple Myeloma: A Patient’s Journey
2/04/23
1 item of Media coverage
Press/Media
-
DDD Workshop Concludes on Day 21: Pharma industry-academia collaboration a win-win for new drugs
2/04/23
1 item of Media coverage
Press/Media
-
NYC Mayor Adams Joined Top Biomedical Researchers to Usher in Center for Engineering and Precision Medicine at Hudson Research Center
Jonathan Dordick, Deepak Vashishth, & Priti Balchandani
2/04/23
1 item of Media coverage
Press/Media
-
Caribou Biosciences Provides Updates on Allogeneic CAR-T Clinical Trials
31/03/23
1 item of Media coverage
Press/Media
-
B-Roll Package: Grand Opening of the Center For Engineering and Precision Medicine March 29, 2023
Jonathan Dordick, Deepak Vashishth, & Priti Balchandani
31/03/23
85 items of Media coverage
Press/Media